Diabetes and Peripheral Neuropathies: 70% reduction in pain with MiS laser

23 January 2025 - Research -
Share

Neuropathic pain is a debilitating condition caused by lesions or diseases that affect the somatosensory nervous system, often resistant to traditional treatments such as anti-inflammatories or opioids. Diabetes, a major cause of neuropathic pain, can lead to diabetic peripheral neuropathy, characterised by pain, numbness and burning sensations, with a significant impact on quality of life.

The study on a patient with type 2 diabetes mellitus

This clinical case highlights the effectiveness of using the MiS laser device, belonging to the patented MLS® family and designed to treat peripheral neuropathies, on a 67-year-old woman who was diagnosed with type II diabetes mellitus (adult-onset diabetes) in 2008, for which she has been undergoing insulin therapy since 2014. 
The patient had hip osteoarthritis (coxarthrosis) on both sides and knee osteoarthritis (gonarthrosis) on the right side. In 2019 she began to complain of pain, numbness and a burning feeling in her legs and feet, symptoms that initially appeared on the right side and afterwards, in 2020, also on the left side.
In October 2022, she was diagnosed with distal sensorimotor polyneuropathy in the lower limbs. The electromyography (EMG) showed axonal degeneration and partial segmental demyelination, more marked in the sensory nerve fibres. The patient also reported a loss of skin sensitivity in the lateral part of the left thigh.

The turning point: treatment with MLS® Laser Therapy

Despite conventional treatments, her symptoms persisted until, in November 2023, she underwent MLS® Laser Therapy. The therapy included six sessions over two weeks: each session targeted the feet and lower limbs with specific parameters based on EU MDR approved clinical guidelines.
Initially with scan treatment on the dorsal and plantar area of both feet and subsequently in fixed-point mode on both lower limbs.
The patient reported significant relief from symptoms:

  • the disappearance of the burning and numbness in the left leg after four sessions and in the right leg after five. 
  • The improvement in skin sensitivity. 

An assessment using the Neuropathic Pain Symptom Inventory (NPSI) showed a 70% reduction in pain, going from 67/100 to 20/100. The benefits were confirmed at one-month follow-up.

MiS laser and treatment of peripheral neuropathies

From a biological point of view, treatment with MiS promotes the recovery of damaged nerve fibres in the lesion area, as confirmed by histological and immunohistochemical analyses. In particular, reorganisation of the sheath is important for both nerve trophism and conduction. This case highlights the potential of MiS as an effective and non-invasive alternative for patients who are refractory to traditional treatments, paving the way for better results in the management of neuropathic pain.

Testo a Destra
Immagine 30%/Testo 60%
MiS laser for neuropathic pain management

Successful Management of Diabetic Peripheral Neuropathic Pain Using MiS MLS® Laser Therapy: A Case Report
I. Todorov
Energy for Health [24], 2024

READ THE RESEARCH

You might also be interested in ...

See all articles

Hilterapia and nerve function
Blog - 04/11/2024
Exploring the Effects of Hilterapia® on Skin Temperature and Nerve Function
A recent study conducted by Alayat et al. (2024) is the first to examine the effects of Hilterapia® - pulsed Nd:YAG laser source (1064nm) - on skin temperature and nerve function in healthy...
MLS Laser Therapy Speech in Brasov, Romania
News - 30/10/2024
Romania: ASA at the National Congress of Physical Medicine and Rehabilitation
MLS® Laser Therapy and some of its flagship devices could not miss out on attending the “National Congress of Physical Medicine and Rehabilitation” in Brasov (Romania, 16-19 October).
AIS treatment | A research with MLS
Blog - 17/09/2024
MLS® Laser Therapy, Schroth Therapy and Scoliosis: a study confirms a rapid and effective treatment
The scientific paper demonstrated the effectiveness of the combination of MLS® Laser Therapy in laser puncture mode with Schroth therapy in the treatment of adolescent idiopathic scoliosis (AIS).
Press - 23/01/2025
Kanal D Romania: MLS® an effective and decisive solution in physiotherapy and post-Covid treatments
Anti-inflammatory, muscle relaxant and effective in rapidly reducing pain, MLS® Laser Therapy is the recommended therapy to successfully treat various muscular diseases.
Press - 23/01/2025
Capital News: MLS® Laser Therapy transforms pain management in Africa
New valuable milestones for MLS® Laser Therapy, which is confirmed as a decisive therapy in pain management.
Diabetic Peripheral Neuropathic Pain Using MiS MLS Laser
Blog - 23/01/2025
Diabetes and Peripheral Neuropathies: 70% reduction in pain with MiS laser
This clinical case highlights the effectiveness of using the MiS laser device on a 67-year-old woman who was diagnosed with type II diabetes mellitus in 2008.